Skip to main content
Have a personal or library account? Click to login
Cathepsin X in serum from patients with colorectal cancer: relation to prognosis Cover

Cathepsin X in serum from patients with colorectal cancer: relation to prognosis

Open Access
|Jul 2012

References

  1. Turk V, Kos J, Turk B. Cysteine cathepsins (proteases)-on the main stage of cancer?2004;: 409-10.
  2. Strojan P. Cysteine cathepsins and stefins in head and neck cancer: an update of clinical studies.2008;: 69-81.
  3. Ardebili SY, Zajc I, Gole B, Campos B, Herold-Mende C, Drmota S et al. CD133/prominin1 is prognostic for GBM patient's survival, but inversely correlated with cysteine cathepsins' expression in glioblastoma derived spheroids.2011;: 102-15.
  4. Kos J, Lah TT. Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer (review).1998;: 1349-61.
  5. Kos J, Sekirnik A, Premzl A, Zavašnik Bergant V, Langerholc T, Turk B, et al. Carboxypeptidases cathepsins X and B display distinct protein profile in human cells and tissues.2005;: 103-13.
  6. Kos J, Jevnikar Z, Obermajer N. The role of cathepsin X in cell signalling.2009;: 164-6.
  7. Obermajer N, Jevnikar Z, Doljak B, Sadaghiani AM, Bogyo M, Kos J. Cathepsin X-mediated β2-integrin activation results in nanotube outgrowth.2009;: 1126-34.
  8. Nascimento FD, Rizzi CC, Nantes IL, Stefe I, Turk B, Carmona AK, et al. Cathepsin X binds to cell surface heparan sulfate proteoglycans.2005;: 323-32.
  9. Obermajer N, Repnik U, Jevnikar Z, Turk B, Kreft M, Kos J. Cysteine protease cathepsin X modulates immune response via activation of β2 integrins.2008;: 76-88.
  10. Obermajer N, Doljak B, Jamnik P, Fonovič UP, Kos J. Cathepsin X cleaves the C-terminal dipeptide of alpha- and gamma-enolase and impairs survival and neuritogenesis of neuronal cells.2009;: 1685-96.
  11. Staudt DN, Aicher KW, Kalbacher H, Stevanovic S, Carmona KA, Bogyo M, et al. Cathepsin X is secreted by human osteoblasts, digests CXCL-12 and impairs adhesion of hematopoietic stem and progenitor cells to osteoblasts.2010;: 1452-60.
  12. Krueger S, Kalinski T, Hundertmark T, Wex T, Küster D, Peitz U, et al. Upregulation of cathepsin X in Helicobacter pylori gastritis and gastric cancer.2005;: 32-42.
  13. Nägler DK, Lechner AM, Oettl A, Kozaczynska K, Scheuber HP, Gippner-Steppert C, et al. An enzyme-linked immunosorbent assay for human cathepsin X, a potential new inflamatory marker.2006;: 241-50.
  14. Baker AR, Zalwango S, Malone LL, Igo RP Jr, Qiu F, Nsereko M, et al. Genetic susceptibility to tuberculosis associated with cathepsin Z haplotype in a Ugandan household contact study.2011;: 426-30.
  15. Ratovitski T, Chiqhladze E, Waldron E, Hirschhorn RR, Ross CA. Cysteine proteases bleomycin hydrolase and cathepsin Z mediate N-terminal proteolysis and toxicity of mutant huntingtin.2011;: 12578-89.
  16. Hidaka S, Yasutake T, Takeshita H, Kondo M, Tsuji T, Nanashima A, et al. Differences in 20q13.2 Copy Number between Colorectal Cancers with and without liver metastasis.2000;: 2712-7.
  17. Bar-Shira A, Pinthus HJ, Rozovsky U, Goldstein M, Sellers RW, Yaron Y, et al. Multiple genes in human 20q13 chromosomal region are involved in an advanced prostate cancer xenograft.2002;: 6803-7.
  18. Nägler DK, Krüger S, Kellner A, Ziomek E, Menard R, Buhtz P, et al. Upregulation of Cathepsin X in prostate cancer and prostatic intraepithelial neoplasia.2004;: 109-19.
  19. Rumpler G, Becker B, Hafner C, McClelland M, Stolz W, Landthaler M, et al. Identification of differentially expressed genes in models of melanoma progression by cDNA array analysis: SPARC, MIF and a novel cathepsin protease characterize aggressive phenotypes.2003;: 761-71.
  20. Sevenich L, Schurigt U, Sachse K, Gajda M, Werner F, Müller S, et al. Synergistic antitumor effects of combined cathepsin B and cathepsin Z deficiencies on breast cancer progression and metastasis in mice.2010;: 2497-502.
  21. Kraus S, Bunsen T, Schuster S, Cichoń MA, Tacke M, Reinheckel T, et al. Cellular senescence induced by cathepsin X downregulation.2011;: 678-86.
  22. Decock J, Obermajer N, Vozelj S, Hendrickx W, Paridaens R, Kos J. Cathepsin B, cathepsin H, cathepsin X and cystatin C in sera of patients with early-stage and inflammatory breast cancer.2008;: 161-8.
  23. Kolwijck E, Kos J, Obermajer N, Span PN, Thomas CM, Massuger LF, et al. The balance between extracellular cathepsins and cystatin C is of importance for ovarian cancer.2010;: 591-9.
  24. Wang J, Chen L, Li Y, Guan XY. Overexpression of Cathepsin Z contributes to tumor metastasis by inducing epithelial-mesenchymal transition of hepatocellular carcinoma.2011;: e24967.
  25. Fonovic PU, Kos J. Efficient removal of Cathepsin L from active Cathepsin X using immunoprecipitation technique.2009;: 985-8.
  26. Brenner H, Bouvier AM, Foschi R, Hackl M, Larsen IK, Lemmens V, et al. Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: The EUROCARE study.2011; doi: 10.1002/ijc.26192.
  27. Velenik V. Post-treatment surveillance in colorectal cancer.2010,: 135-41.
  28. Zavoral M, Suchanek S, Zavada F, Dusek L, Muzik J, Seifert B, et al. Colorectal cancer screening in Europe.2009;: 5907-15.
  29. Booth RA. Minimally invasive biomarkers for detection and staging of colorectal cancer.2007;: 87-96.
  30. Nielsen HJ, Brünner N, Frederiksen C, Lomholt AF, King D, Jørgensen LN, et al. Plasma tissue inhibitor of metalloproteinases-1 (TIMP-1): a novel biological marker in the detection of primary colorectal cancer. Protocol outlines of the Danish-Australian endoscopy study group on colorectal cancer detection.2008;: 242-8.
  31. Nielsen HJ, Christensen IJ, Brünner N. A novel prognostic index in colorectal cancer defined by serum carcinoembryonic antigen and plasma tissue inhibitor of metalloproteinases-1.2010;: 200-7.
  32. Obermajer N, Premzl A, Zavašnik Bergant T, Turk B, Kos J. Carboxypeptidase cathepsin X mediates β2-integrin-dependent adhesion of differentiated U-937 cells.2006;: 2515-27.
  33. Nägler DK, Zhang R, Tam W, Sulea T, Purisima EO, Ménard R. Human cathepsin X: A cysteine protease with unique carboxypeptidase activity.1999;: 12648-54.
  34. Vasiljeva O, Papazoglou A, Krüger A, Brodoefel H, Korovin M, Deussing J, et al. Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer.2006;: 5242-50.
  35. Lines KE, Chelala C, Dmitrovic B, Wijesuriya N, Kocher HM, Marshall JF, et al. S100P-binding protein, S100PBP, mediates adhesion through regulation of cathepsin Z in pancreatic cancer cells.2012;: 1485-94.
  36. Nägler DK, Mènard R: Human cathepsin X: a novel cysteine protease of the papain family with a very short proregion and unique insertions.1998;: 135-9.
  37. Santamaría I, Velasco G, Pendás AM, Fueyo A, López-Otín C. Cathepsin Z, a novel human cysteine proteinase with a short propeptide domain and unique chromosomal location.1998;: 16816-23.
  38. Hafner A, Obermajer N, Kos J. γ-1-syntrophin mediates trafficking of γ-enolase towards the plasma membrane and enhances its neurotrophic activity.2010;: 246-58.
  39. Hafner A, Obermajer N, Kos J. γ-Enolase C-terminal peptide promotes cell survival and neurite ougrowth by activation of PI3K/Akt and MAPK/ERK signalling pathways.2012;: 439-50.
DOI: https://doi.org/10.2478/v10019-012-0040-0 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 207 - 212
Published on: Jul 24, 2012
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2012 Tjasa Vizin, Ib Christensen, Hans Nielsen, Janko Kos, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.